With the rising global population, the purpose of birth control stays high consistently. The reasons for using contraceptives can be numerous, but the ultimate need is to achieve birth control and prevent unwanted pregnancies. The rising number of unintended pregnancies which is making the global organizations and associations vigilant is the sole reason for the growth of the contraceptive market. According to the World Health Organization (WHO), emergency contraception such as oral contraceptive pills, copper intrauterine devices can prevent up to 95% of pregnancies, when taken within 5 days after intercourse. Due to rise in awareness and rising affordability of tools for general masses, the contraceptive market is poised to witness a positive growth. The global Contraceptive Market size was evaluated as $21.5 billion in 2018, and the market is estimated to rise at a CAGR of 6.20%, during the forecast period 2019-2025.
Incidences of Unwanted Pregnancies Boost the Contraceptives Market Growth
Unwanted pregnancy often result in abortion, miscarriage, or unplanned birth. The level of unmet need or unwanted pregnancy for family planning has declined substantially from 22% to 12% during 1970-2017. These indicators and rapid decline in the level of unintended pregnancies is attributed to rising growth of the contraceptives market.
Along with that, the WHO with other member government agencies are promoting these detrimental effects of unwanted pregnancies. These instances from the governments to educate people are thriving the growth of the contraceptive market.
North America Leading the Global Contraceptives Market
According to the United Nations, in 2017, about 75% of married or in-union women of reproductive age use contraceptives in North America. This contraception include modern and traditional methods. But, modern contraceptive methods are high in demand in North America, owing to increasing healthcare investments and education by the governments. Besides, the unmet need for family planning is the lowest in the region, which accounts for less than 10%. These figures indicate that the demand for contraceptives is significantly growing with the rising population. As a result, North America contraceptives market occupied a share of 34% in the global marketplace.
Reversible Nature of Intrauterine Devices Contribute in the Contraceptives Market Growth–
Intrauterine Devices (IUDs) are the most effective and widely used contraception method around the world. It is long-acting and has a low failure rate. Most of the women believe that it is convenient, effective and safe to use. Moreover, the global usage of IUDs has increased over the past few decades. Furthermore, according to the WHO, a copper-bearing IUD is an efficient form of emergency contraception. Consequently, the rising demand of IUD contraceptive method is attributed to its reversible nature. The prevalence is widely seen in Asia, reflecting the predominant usage among Chinese women. Owing to all these demands from across the world, the global intrauterine devices market is projected to rise at a CAGR of 5.7%, during the forecast period.
Contraceptive Market Growth Drivers and Trends –
Increasing Awareness of Sexually Transmitted Diseases (STDs) and Sexually Transmitted Infections (STIs) Boost the Awareness of Contraceptives -
According to the International Planned Parenthood Federation, each year around 350 million people need treatment for STIs. Condoms are primary contraceptive methods to protect from STDs and STIs, and consistent and correct usage of these contraceptives can reduce the risk of mentioned diseases. Moreover, governments across the world are promoting the usage of contraceptives, to lessen the number of STD and STI cases. Owing to these reasons, the contraceptives market is thriving with increasing awareness of STDs and STIs.
Government and Healthcare Associations Initiatives Boost the Contraceptive Market Growth –
Healthcare organizations and associations around the world are inculcating awareness of contraceptives among the population. Besides, few organizations such as the International Planned Parenthood Federation (IPPF) also deliver sexual and reproductive healthcare services, besides educating the population. These activities from the governments and associations are promoting the global contraceptive market growth.
Innovations Propel the Contraceptive Patches Market
The contraceptive patch is a convenient and effective way of birth control. Companies such as Ortho Evra, Xulane delivered these contraceptive hormonal patches which are approved by the U.S. Food and Drug Administration. However, the former discontinued in the U.S. and continued in Europe and Canada, with continual innovations to deliver hormonal patches, with fewer estrogen levels that effectively reduce the chances of unwanted pregnancies. Advances as such are disrupting the contraceptive hormonal patch market.
For instance, recent research supported by the U.S. Agency for International Development (USAID) found out a new technique to administer contraceptive hormones with the help of special aids on jewelry items such as rings, necklaces, earrings, or wristwatches. This contraceptive jewelry adapts transdermal patch technology. As the jewelry is a part of women daily routine, this method of administering hormones increases the chances to acquaint well with the drug regimen. Therefore, this procedure could more commendably allow women to reduce the risk of unintended pregnancies. These kind of researches are encouraging the adoption of contraceptives among women thereby, amplifying the contraceptive market growth.
Family Planning Organizations and Programs Surge the Contraceptive Market Growth -
As a part of “Family Planning 2020” summits, the governments and private sectors are coming together to promote the need for sexual and reproductive health. Core funding is supported by the nations to mandate the regulations that monitor and stimulate the need for family planning (FP) and sexual and reproductive health. They are committed to expand access to family planning commodities and enhance family planning services. Besides, these services improve the access to high quality and effective contraceptive services and enhance the decision making ability in the environments that can address the social, economic, cultural, and social barriers. This, in turn, enables women and girls to be more aware and help in taking decisions about their reproductive health and fertility. This kind of initiatives as a part of family planning programs and associations is boosting the awareness towards the usage of contraceptives, thereby increasing the growth of the contraceptive industry.
Solutions and Awareness of Malnutrition and Preterm Births Boosting the Growth of the Contraceptives Market
According to the WHO, about 45% of deaths are related to under-nutrition in children under age 5 years. These cases are predominant in low-and middle-income countries. Most of the malnutrition cases are attributed to social, medical, and economic challenges, and unintended pregnancies which happen mostly due to unmet need for contraceptives.
Secondly, every single year, globally about 15 million babies are born preterm i.e., before completing 37 weeks of the gestation period, and this number is further increasing. Common causes of these preterm births include chronic conditions, genetic influences, other infections, and lack of awareness about contraceptives to prevent unwanted pregnancies.
To mitigate these scenarios, governments and the WHO members are promoting the solutions to the complications and awareness of effective contraceptives, which is further boosting the growth of the contraceptives market.
Top Companies in the Contraceptives Industry by Market Capitalization
Core companies thriving to hold their position in the global contraceptives market are Cooper Surgical, Inc. (U.S.), Pfizer, Inc. (U.S.), Actavis, Inc. (U.S.), Bayer AG (Germany), The Female Health Company (U.S.), Teva Pharmaceutical Industries Limited (Israel), Church & Dwight, Co., Inc. (U.S.), Medisafe Distribution Inc. (Canada), Merck & Co., Inc. (U.S.), and Mayer Laboratories, Inc. (U.S.).
Contraceptive pills and drugs intake that treat hormonal imbalances and produce estrogen levels and hormones nearly similar to estrogen produced in woman body are gaining huge traction in this market. In addition, research related to vaginal ring and male contraceptives are further boosting the market growth.
Few of the global players’ strategies include:
Product launch – In 2018, Mylan a global pharmaceutical company launched a generic version of oral contraceptive, which was approved by the FDA. This product can be used by women to prevent unwanted pregnancy and for the treatment of acne vulgaris in women of age above 14 years.
Acquisition - In 2017, the Cooper Companies, Inc., a leading provider of women’s healthcare solutions has acquired PARAGARD IUD from Teva Pharmaceutical Industries Ltd., for about $1.1 billion. This acquisition marks the expansion of product portfolio related to IUDs by the Cooper Companies.
Talk to one of our sales representative about the full report by providing your details in the link below:
A. Hormonal Contraception Market
B. Combined Hormonal Contraceptives Market
Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
To request for a Quote, provide your details in the below link:
Mr. Venkat Reddy
Email: [email protected]
Contact Sales: +1-614-588-8538 (Ext-101)
About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.